Arcellx/$ACLX
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Arcellx
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.
Ticker
$ACLX
Sector
Primary listing
Employees
163
Headquarters
Website
Arcellx Metrics
BasicAdvanced
$4.2B
-
-$3.94
0.31
-
Price and volume
Market cap
$4.2B
Beta
0.31
52-week high
$94.07
52-week low
$47.86
Average daily volume
1.1M
Financial strength
Current ratio
3.987
Quick ratio
3.932
Long term debt to equity
10.056
Total debt to equity
11.751
Interest coverage (TTM)
-232.78%
Profitability
EBITDA (TTM)
-235.726
Gross margin (TTM)
-368.45%
Net profit margin (TTM)
-607.01%
Operating margin (TTM)
-675.67%
Effective tax rate (TTM)
-0.71%
Revenue per employee (TTM)
$220,000
Management effectiveness
Return on assets (TTM)
-21.34%
Return on equity (TTM)
-47.18%
Valuation
Price to revenue (TTM)
110.847
Price to book
9.42
Price to tangible book (TTM)
9.42
Price to free cash flow (TTM)
-19.78
Free cash flow yield (TTM)
-5.06%
Free cash flow per share (TTM)
-3.633
Growth
Revenue change (TTM)
-76.96%
Earnings per share change (TTM)
408.68%
3-year earnings per share growth (CAGR)
-16.19%
Arcellx News
AllArticlesVideos
Why Is Arcellx Stock Surging Today?
Benzinga·1 week ago
Arcellx Announces New Positive Data for Its iMMagine-1 Study in Patients with Relapsed and/or Refractory Multiple Myeloma
Business Wire·1 week ago
Arcellx to Host Investor Relations Event During the 67th ASH Annual Meeting and Exposition
Business Wire·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Arcellx stock?
Arcellx (ACLX) has a market cap of $4.2B as of December 16, 2025.
What is the P/E ratio for Arcellx stock?
The price to earnings (P/E) ratio for Arcellx (ACLX) stock is 0 as of December 16, 2025.
Does Arcellx stock pay dividends?
No, Arcellx (ACLX) stock does not pay dividends to its shareholders as of December 16, 2025.
When is the next Arcellx dividend payment date?
Arcellx (ACLX) stock does not pay dividends to its shareholders.
What is the beta indicator for Arcellx?
Arcellx (ACLX) has a beta rating of 0.31. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.